Fernando Aguirre's most recent trade in Synchrony Financial was a trade of 15 Dividend Equivalent Unit done at an average price of $71.5 . Disclosure was reported to the exchange on Aug. 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 71.47 per share. | 15 Aug 2025 | 15 | 27,112 (0%) | 0% | 71.5 | 1,072 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 66.74 per share. | 30 Jun 2025 | 825 | 27,097 (0%) | 0% | 66.7 | 55,061 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 60.47 per share. | 15 May 2025 | 2,263 | 39,150 (0%) | 0% | 60.5 | 136,844 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 60.47 per share. | 15 May 2025 | 17 | 26,272 (0%) | 0% | 60.5 | 1,028 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 52.94 per share. | 31 Mar 2025 | 1,039 | 26,255 (0%) | 0% | 52.9 | 55,005 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 65.31 per share. | 18 Feb 2025 | 13 | 25,216 (0%) | 0% | 65.3 | 849 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 65.01 per share. | 31 Dec 2024 | 635 | 25,203 (0%) | 0% | 65.0 | 41,281 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 57.10 per share. | 21 Nov 2024 | 2,364 | 36,887 (0%) | 0% | 57.1 | 134,984 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 65.00 per share. | 15 Nov 2024 | 15 | 24,568 (0%) | 0% | 65 | 975 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 49.88 per share. | 30 Sep 2024 | 827 | 24,553 (0%) | 0% | 49.9 | 41,251 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 45.87 per share. | 15 Aug 2024 | 23 | 23,726 (0%) | 0% | 45.9 | 1,055 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 47.19 per share. | 30 Jun 2024 | 875 | 23,703 (0%) | 0% | 47.2 | 41,291 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 57.52 per share. | 16 May 2024 | 2,347 | 34,523 (0%) | 0% | 57.5 | 134,999 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 44.15 per share. | 15 May 2024 | 26 | 22,828 (0%) | 0% | 44.2 | 1,148 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 43.12 per share. | 31 Mar 2024 | 957 | 22,802 (0%) | 0% | 43.1 | 41,266 | Common Stock |
Synchrony Financial | Aguirre Fernando | Director | Grant, award, or other acquisition of securities at price $ 39.85 per share. | 15 Feb 2024 | 33 | 21,845 (0%) | 0% | 39.8 | 1,315 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 38.19 per share. | 31 Dec 2023 | 1,081 | 21,812 (0%) | 0% | 38.2 | 41,283 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 69.13 per share. | 15 Nov 2023 | 1,998 | 32,176 (0%) | 0% | 69.1 | 138,122 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 29.16 per share. | 09 Nov 2023 | 45 | 20,731 (0%) | 0% | 29.2 | 1,312 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 30.57 per share. | 30 Sep 2023 | 1,350 | 20,686 (0%) | 0% | 30.6 | 41,270 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 34.41 per share. | 10 Aug 2023 | 39 | 19,336 (0%) | 0% | 34.4 | 1,342 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 33.92 per share. | 30 Jun 2023 | 1,217 | 19,297 (0%) | 0% | 33.9 | 41,281 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 69.31 per share. | 18 May 2023 | 1,329 | 30,178 (0%) | 0% | 69.3 | 92,113 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 27.08 per share. | 12 May 2023 | 48 | 18,080 (0%) | 0% | 27.1 | 1,300 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 29.08 per share. | 31 Mar 2023 | 1,419 | 18,032 (0%) | 0% | 29.1 | 41,265 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 35.77 per share. | 17 Feb 2023 | 35 | 16,613 (0%) | 0% | 35.8 | 1,252 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 32.86 per share. | 31 Dec 2022 | 1,256 | 16,578 (0%) | 0% | 32.9 | 41,272 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 94.93 per share. | 17 Nov 2022 | 1,323 | 28,849 (0%) | 0% | 94.9 | 125,592 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 38.73 per share. | 10 Nov 2022 | 30 | 15,322 (0%) | 0% | 38.7 | 1,162 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 28.19 per share. | 30 Sep 2022 | 1,464 | 15,292 (0%) | 0% | 28.2 | 41,270 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 36.11 per share. | 11 Aug 2022 | 28 | 13,828 (0%) | 0% | 36.1 | 1,011 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 27.62 per share. | 30 Jun 2022 | 1,494 | 13,800 (0%) | 0% | 27.6 | 41,264 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 33.04 per share. | 12 May 2022 | 24 | 12,306 (0%) | 0% | 33.0 | 793 | Dividend Equivalent Unit |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 97.99 per share. | 11 May 2022 | 1,282 | 27,526 (0%) | 0% | 98.0 | 125,623 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 34.81 per share. | 31 Mar 2022 | 1,186 | 12,282 (0%) | 0% | 34.8 | 41,285 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 43.65 per share. | 17 Feb 2022 | 17 | 11,096 (0%) | 0% | 43.6 | 742 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 31 Dec 2021 | 890 | 11,079 (0%) | 0% | 46.4 | 41,287 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 92.73 per share. | 17 Nov 2021 | 1,253 | 26,244 (0%) | 0% | 92.7 | 116,191 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 50.20 per share. | 12 Nov 2021 | 15 | 10,189 | - | 50.2 | 753 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 48.88 per share. | 30 Sep 2021 | 844 | 10,174 (0%) | 0% | 48.9 | 41,255 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 51.62 per share. | 12 Aug 2021 | 16 | 9,330 | - | 51.6 | 826 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 48.52 per share. | 30 Jun 2021 | 696 | 9,314 (0%) | 0% | 48.5 | 33,770 | Common Stock |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 84.27 per share. | 13 May 2021 | 1,379 | 24,991 (0%) | 0% | 84.3 | 116,208 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 45.26 per share. | 13 May 2021 | 23 | 8,618 | - | 45.3 | 1,041 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 40.66 per share. | 31 Mar 2021 | 831 | 8,595 (0%) | 0% | 40.7 | 33,788 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 37.91 per share. | 16 Feb 2021 | 35 | 7,764 | - | 37.9 | 1,327 | Dividend Equivalent Unit |
CVS Health | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 66.35 per share. | 18 Nov 2020 | 1,752 | 23,612 (0%) | 0% | 66.3 | 116,245 | Common Stock |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 29.11 per share. | 12 Nov 2020 | 45 | 6,756 | - | 29.1 | 1,310 | Dividend Equivalent Unit |
Synchrony Financial | Fernando Aguirre | Director | Grant, award, or other acquisition of securities at price $ 26.17 per share. | 30 Sep 2020 | 1,290 | 6,711 (0%) | 0% | 26.2 | 33,759 | Common Stock |